A detailed history of Stratos Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 6,699 shares of AZN stock, worth $431,683. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,699
Previous 6,566 2.03%
Holding current value
$431,683
Previous $512,000 1.76%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$76.67 - $87.62 $10,197 - $11,653
133 Added 2.03%
6,699 $521,000
Q2 2024

Jul 24, 2024

BUY
$66.81 - $80.83 $21,579 - $26,108
323 Added 5.17%
6,566 $512,000
Q1 2024

Apr 16, 2024

BUY
$61.03 - $69.57 $129,322 - $147,418
2,119 Added 51.38%
6,243 $422,000
Q4 2023

Jan 24, 2024

BUY
$61.89 - $69.28 $255,234 - $285,710
4,124 New
4,124 $277,000
Q4 2022

Jan 19, 2023

BUY
$54.21 - $70.44 $932,140 - $1.21 Million
17,195 New
17,195 $0

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Stratos Wealth Advisors, LLC Portfolio

Follow Stratos Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Advisors, LLC with notifications on news.